Literature DB >> 3162228

Linkage of a polymorphic marker for the type III collagen gene (COL3A1) to atypical autosomal dominant Ehlers-Danlos syndrome type IV in a large Belgian pedigree.

A C Nicholls1, A De Paepe, P Narcisi, R Dalgleish, F De Keyser, M Matton, F M Pope.   

Abstract

We have examined a large family in which eleven members have a form of autosomal dominant Ehlers-Danlos syndrome type IV. Analysis of fibroblast cultures from affected individuals showed a partial deficiency of type III collagen production. The protein produced was, however, normal in all aspects examined. Using a restriction site polymorphism associated with the structural gene for human type III collagen (COL3A1), we have found tight linkage between the low frequency polymorphic allele and the clinical expression of the disease (lod = 3.86 at 0 = 0), identifying the type III collagen gene as the disease locus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162228     DOI: 10.1007/BF00291676

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  17 in total

1.  Isolation of cDNA and genomic clones encoding human pro-alpha 1 (III) collagen. Partial characterization of the 3' end region of the gene.

Authors:  M L Chu; D Weil; W de Wet; M Bernard; M Sippola; F Ramirez
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

2.  Chromosomal assignments of the genes coding for human types II, III, and IV collagen: a dispersed gene family.

Authors:  E Solomon; L R Hiorns; N Spurr; M Kurkinen; D Barlow; B L Hogan; R Dalgleish
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  The estimation of two collagens from human dermis by interrupted gel electrophoresis.

Authors:  B Sykes; B Puddle; M Francis; R Smith
Journal:  Biochem Biophys Res Commun       Date:  1976-10-18       Impact factor: 3.575

4.  Type IX Ehlers-Danlos syndrome. A new variant with pathognomonic radiographic features.

Authors:  D J Sartoris; L Luzzatti; D D Weaver; J D Macfarlane; D W Hollister; B R Parker
Journal:  Radiology       Date:  1984-09       Impact factor: 11.105

5.  An RFLP associated with the human type III collagen gene (COL3A1).

Authors:  R Dalgleish; M Woodhouse; S Reeders
Journal:  Nucleic Acids Res       Date:  1985-06-25       Impact factor: 16.971

6.  Unusual familial manifestation of Ehlers-Danlos syndrome.

Authors:  M T Matton; A De Paepe; F De Keyser; B François
Journal:  Prog Clin Biol Res       Date:  1982

7.  Molecular cloning and carboxyl-propeptide analysis of human type III procollagen.

Authors:  H R Loidl; J M Brinker; M May; T Pihlajaniemi; S Morrow; J Rosenbloom; J C Myers
Journal:  Nucleic Acids Res       Date:  1984-12-21       Impact factor: 16.971

8.  Human alpha 1(III) and alpha 2(V) procollagen genes are located on the long arm of chromosome 2.

Authors:  B S Emanuel; L A Cannizzaro; J M Seyer; J C Myers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

9.  Patients with Ehlers-Danlos syndrome type IV lack type III collagen.

Authors:  F M Pope; G R Martin; J R Lichtenstein; R Penttinen; B Gerson; D W Rowe; V A McKusick
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

10.  Ehlers-Danlos syndrome type IV: cosegregation of the phenotype to a COL3A1 allele of type III procollagen.

Authors:  P Tsipouras; P H Byers; R C Schwartz; M L Chu; D Weil; G Pepe; S B Cassidy; F Ramirez
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

View more
  17 in total

1.  A 27-bp deletion from one allele of the type III collagen gene (COL3A1) in a large family with Ehlers-Danlos syndrome type IV.

Authors:  A J Richards; J C Lloyd; P Narcisi; P N Ward; A C Nicholls; A De Paepe; F M Pope
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

2.  The molecular defect in a family with mild atypical osteogenesis imperfecta and extreme joint hypermobility: exon skipping caused by an 11-bp deletion from an intron in one COL1A2 allele.

Authors:  A C Nicholls; J Oliver; D V Renouf; D A Heath; F M Pope
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

3.  Defining DNA diagnostic tests appropriate or standard clinical care.

Authors:  R V Lebo; G Cunningham; M J Simons; L J Shapiro
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

4.  Spontaneous aortic rupture in a 22-year-old.

Authors:  M A Memon; C M Nicholson; J Clayton-Smith
Journal:  Postgrad Med J       Date:  1996-05       Impact factor: 2.401

Review 5.  Prenatal diagnosis and prevention of inherited abnormalities of collagen.

Authors:  F M Pope; S C Daw; P Narcisi; A R Richards; A C Nicholls
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

6.  Linkage of a polymorphic marker for the type III collagen gene (COL3A1) to atypical autosomal dominant Ehlers-Danlos syndrome type IV in a large Belgian pedigree.

Authors:  A C Nicholls; A De Paepe; P Narcisi; R Dalgleish; F De Keyser; M Matton; F M Pope
Journal:  Hum Genet       Date:  1988-03       Impact factor: 4.132

7.  A T+6 to C+6 mutation in the donor splice site of COL3A1 IVS7 causes exon skipping and results in Ehlers-Danlos syndrome type IV.

Authors:  J Lloyd; P Narcisi; A Richards; F M Pope
Journal:  J Med Genet       Date:  1993-05       Impact factor: 6.318

8.  A single base mutation in the gene for type III collagen (COL3A1) converts glycine 847 to glutamic acid in a family with Ehlers-Danlos syndrome type IV. An unaffected family member is mosaic for the mutation.

Authors:  A J Richards; P N Ward; P Narcisi; A C Nicholls; J C Lloyd; F M Pope
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

Review 9.  Diagnosis of genetic disease using recombinant DNA. Supplement.

Authors:  D N Cooper; J Schmidtke
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

10.  Molecular defects of type III procollagen in Ehlers-Danlos syndrome type IV.

Authors:  A Superti-Furga; B Steinmann; F Ramirez; P H Byers
Journal:  Hum Genet       Date:  1989-05       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.